These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7860391)

  • 41. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
    Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
    Douglas JG; Arndt CA; Hawkins DS
    Eur J Cancer; 2007 Apr; 43(6):1045-50. PubMed ID: 17368885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
    Smith LM; Anderson JR; Qualman SJ; Crist WM; Paidas CN; Teot LA; Pappo AS; Link MP; Grier HE; Wiener ES; Breneman JC; Raney RB; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Oct; 19(20):4058-64. PubMed ID: 11600608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
    Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
    J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
    Winter S; Fasola S; Brisse H; Mosseri V; Orbach D
    Pediatr Blood Cancer; 2015 Nov; 62(11):1935-41. PubMed ID: 26150380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aggressive chemotherapy, organ-preserving surgery, and high-dose-rate remote brachytherapy in the treatment of rhabdomyosarcoma in infants and young children.
    Nag S; Grecula J; Ruymann FB
    Cancer; 1993 Nov; 72(9):2769-76. PubMed ID: 8402502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma.
    Pappo AS; Bowman LC; Furman WL; Rao BN; Kun LE; Jenkins JJ; Crom WR; Luo X; Kaste SC; Avery L; Meyer WH; Shapiro DN; Crist WM
    J Pediatr Hematol Oncol; 1997; 19(5):438-42. PubMed ID: 9329466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
    Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
    Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parameningeal rhabdomyosarcoma: results of an international workshop.
    Benk V; Rodary C; Donaldson SS; Flamant F; Maurer H; Treuner I; Carli M; Gehan E
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):533-40. PubMed ID: 8948336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.
    Eaton BR; McDonald MW; Kim S; Marcus RB; Sutter AL; Chen Z; Esiashvili N
    Cancer; 2013 Apr; 119(8):1578-85. PubMed ID: 23280478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal management strategies for rhabdomyosarcoma in children.
    Walterhouse D; Watson A
    Paediatr Drugs; 2007; 9(6):391-400. PubMed ID: 18052409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
    Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
    Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation late effects in children treated for orbital rhabdomyosarcoma.
    Fiorillo A; Migliorati R; Vassallo P; Canale G; Tranfa F; Fariello I; De Chiara C; D'Amore R; Muto P; Bonavolontà G
    Radiother Oncol; 1999 Nov; 53(2):143-8. PubMed ID: 10665792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents.
    Hays DM; Shimada H; Raney RB; Tefft M; Newton W; Crist WM; Lawrence W; Ragab A; Beltangady M; Maurer HM
    Cancer; 1988 May; 61(9):1893-903. PubMed ID: 3281745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of adult rhabdomyosarcoma.
    Ogilvie CM; Crawford EA; Slotcavage RL; King JJ; Lackman RD; Hartner L; Staddon AP
    Am J Clin Oncol; 2010 Apr; 33(2):128-31. PubMed ID: 19770626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 45 GyRBE for group III orbital embryonal rhabdomyosarcoma.
    Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Hol ML; Bradley JA
    Acta Oncol; 2019 Oct; 58(10):1404-1409. PubMed ID: 31530120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.